Vilon
Also known as: Lys-Glu, KE Dipeptide
Key Facts: Vilon
- Category
- Bioregulators
- FDA Status
- Not FDA Approved
- Clinical Status
- Available in Russia - Not FDA approved
- Administration
- Oral capsules or sublingual
- Typical Dose
- 10-20 mg daily
- Frequency
- Once or twice daily
- Evidence Level
- Animal Studies
- Duration
- 10-30 day courses
What to Expect
A synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.
Mechanism of Action
Vilon regulates gene expression in thymic and immune cells. It supports T-cell development and function, potentially reversing age-related thymic involution and immune decline.
Research Summary
Russian studies show immune enhancement and potential longevity benefits. Research demonstrates improved immune parameters in elderly. Part of peptide bioregulator approach.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
10-20 mg daily
10-20 mg daily
Once or twice daily
Khavinson dipeptide bioregulator. Oral or sublingual. Run in 10-30 day cycles for immune support.
Research Dosingⓘ
Scientific studies
Doses from Russian protocols
Doses from Studies
10-20 mg daily
Oral or sublingual
Duration
10-30 day courses
Administration
Oral capsules or sublingual
Timing & Administration
Best Time to Take
Morning
Once daily or as directed
Food Recommendation
With or without food
Why This Timing?
Immune peptides align with the body's natural immune rhythm which is more active during the day.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally very well-tolerated
- ●Brief injection site discomfort
- ●CAUTION: Increased breast cancer in mouse models
- ●Limited human safety data
References
Related Peptides
Peptides commonly compared with Vilon or used in similar applications.
Epithalon
Clinical TrialsA tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties. Based on research by Professor Vladimir Khavinson.
BioregulatorsThymalin
Clinical TrialsA thymic peptide complex used in Russia for immune enhancement and anti-aging. Part of Professor Khavinson's bioregulator peptide research.
BioregulatorsCrystagen
PreclinicalA tripeptide bioregulator supporting immune system function. Demonstrates age-associated immunoprotective properties in spleen tissue. Part of the Khavinson synthesized peptide series.
BioregulatorsPinealon
PreclinicalA synthetic tripeptide bioregulator targeting brain tissue. Part of Khavinson's peptide research, designed to support cognitive function and neuroprotection.
BioregulatorsCartalax
PreclinicalA synthetic tripeptide bioregulator targeting cartilage tissue. Developed for joint health and cartilage regeneration.
BioregulatorsLivagen
PreclinicalA tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
BioregulatorsWant updates on Vilon research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.